It is with deep sadness that LBDA announces the sudden passing of Daniel I. Kaufer, MD, a longtime member of LBDA’s Scientific Advisory Council and investigator in the LBDA Research Center of Excellence at University of North Carolina, Chapel Hill. Dr. Kaufer succumbed to cancer on July 2, 2020 after a brief illness.
A highly respected cognitive/behavioral neurologist, Dr. Kaufer’s research, clinical and educational efforts over the past 25 years centered around LBD and frontotemporal degeneration. Dr. Kaufer developed several important clinical assessment tools, including the Neuropsychiatric Inventory Caregiver Distress (NPI-C) scale and a brief questionnaire version of the Neuropsychiatric Inventory, called the NPI Questionnaire (NPI-Q). He also was lead investigator for one of the first nationwide clinical trials in LBD, sponsored by Axovant. Dr. Kaufer was also an investigator in the DLB Consortium, doing a longitudinal study in the pursuit of an LBD biomarker.
Dr. Kaufer served as Associate Professor of Neurology and Psychiatry, the Division Chief, Cognitive Neurology and Memory Disorders, the founding Director of the UNC Memory Disorders Program and co-Director of the Carolina Alzheimer’s Network.
“Dan volunteered with LBDA for nearly 15 years, lending his time, passion and expertise to benefit the entire LBD community.” stated Angela Taylor, Senior Director of Research and Advocacy at LBDA. “He had a gentle heart and was passionate about improving the quality of life for his patients and family caregivers. He is going to be deeply missed.”
More details about his legacy, details on how to express condolences and how to make memorial donations can be found in his obituary.